Potash Investment Thesis

Potash Investment Thesis-64
“They often start off with some interesting science and then the companies form and start creating different molecules to go after the technology they own,” he said, adding that drug company CEOs often start out as academics or scientists.“The technology has shoes — often the guys will start off at universities and move into commercial.” Cancer treatment is an area that Mc Camant sees as an important area for life sciences investors to consider.He pointed to the high-profile case of NHL hockey star Mario Lemieux, who in 1993 was diagnosed with Hodgkin’s lymphona and was forced to miss games while undergoing aggressive radiation treatments.

“They often start off with some interesting science and then the companies form and start creating different molecules to go after the technology they own,” he said, adding that drug company CEOs often start out as academics or scientists.“The technology has shoes — often the guys will start off at universities and move into commercial.” Cancer treatment is an area that Mc Camant sees as an important area for life sciences investors to consider.He pointed to the high-profile case of NHL hockey star Mario Lemieux, who in 1993 was diagnosed with Hodgkin’s lymphona and was forced to miss games while undergoing aggressive radiation treatments.

Tags: Woodlands Junior School HomeworkPros And Cons Of Online Learning EssayPoints To Compare And Contrast In An EssayA Restaurant Business PlanOrganizer For Writing An EssayReal Estate Business Plan SampleEnglish Creative Writing WorksheetsBowling For Columbine Summary EssayBest Books For Consulting Case StudiesCollege Essay Writing Service Reviews

Within the universe of investment options available to those trying to grow their hard-earned cash, there is perhaps no more compelling investment thesis than the science of life.

Life sciences is a term that is broadly defined as any branch of science — for instance, biology, medicine or ecology — that studies the organization of living organisms, their relationships to each other and the environment.

Number one rule for investors: look at management But given that literally hundreds of companies are conducting research and studies into potential cures, how does an investor separate the wheat from the chaff?

Mc Camant recommended that investors do their homework, and most importantly, look at the management behind life sciences companies.

15, [2012], and are up 12.6% each year over the past three years,” according to investment-research firm Morningstar. INX) stock index gained 10.1 percent during the same period.

The sector is also considered a safe haven due to baby boomers — a large and growing market segment whose consumption of pharmaceuticals and need for an endless array of healthcare services is only going to get more pressing.

For example, those associated with chemotherapy can make the treatment unworthy of the payoff.

Mc Camant equates it to the stock market in terms of risk versus reward.

“You’ve got to be able to interact with your own scientists, the FDA are very detailed and they also need to know and understand the science, and if you’re public you need to deal with Wall Street.

You also need to potentially do partnerships with large and small companies.” Those that do well are the ones that best manage expectations, he noted.

SHOW COMMENTS

Comments Potash Investment Thesis

The Latest from fructaroma.ru ©